SEC Form 4 · accession 0001209191-16-125833
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven B Ruchefsky
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 3, 2016 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | A | 1,950 | $0.00 | A | 87,988 | D | |
| Common StockF2 | holding | — | — | — | 946,420 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F3 | $50.87 | Jun 1, 2016 | A | 7,000 | A | — | May 31, 2026 | Common Stock | 7,000 | 7,000 | D |
Explanation of responses
- F1Includes 86,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on March 27, 2015 in a pro rata distribution and are now owned directly.
- F2The shares are held in the name of Commercial Street Capital, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3The stock option shall vest in 24 successive equal monthly installments following the date of grant.